Only children ages 5 or older can be vaccinated in the U.S.
The Associated Press
Pfizer hopes to tell U.S. regulators how well its COVID-19 vaccine works in the youngest kids by late May or early June. The drugmaker is testing three extra-small doses of its vaccine in children under 5 after two shots didn’t prove quite strong enough. Initial results had been expected last month but the company laid out the latest timeline Tuesday during its discussion of quarterlyCurrently in the U.S., only children ages 5 or older can be vaccinated, using Pfizer’s vaccine — leaving 18 million younger tots unprotected..
Note to readers: if you purchase something through one of our affiliate links we may earn a commission.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer beats Q1 estimates as COVID vaccine and antiviral boost revenuePfizer Inc. undefined posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The...
Consulte Mais informação »
Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesCOVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.
Consulte Mais informação »
Pfizer Sales Soar on Covid-19 Vaccine SalesPfizer logged $25.7 billion in sales in the first-quarter, driven by sales of vaccine Comirnaty and Paxlovid, a pill aimed at reducing severe outcomes from Covid-19
Consulte Mais informação »
Pfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June
Consulte Mais informação »
Pfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June.
Consulte Mais informação »
Pfizer Hopes to Submit Little-Kid Vaccine Data by Early JunePfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
Consulte Mais informação »